Search Results - "Jakoby, Judith"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects

    Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects by Jakoby, Judith, Beuschlein, Felix, Mentz, Susanne, Hantel, Constanze, Süss, Regine

    Published in Oncotarget (22-12-2015)
    “…Due to the inability of classical chemotherapeutic agents to exclusively target tumor cells, these treatments are associated with severe toxicity profiles…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma

    IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma by Beuschlein, Felix, Jakoby, Judith, Mentz, Susanne, Zambetti, Gerard, Jung, Sara, Reincke, Martin, Süss, Regine, Hantel, Constanze

    Published in Molecular and cellular endocrinology (15-06-2016)
    “…Adrenocortical carcinoma (ACC) is a tumor with poor prognosis and limited therapeutic options. Therefore, in addition to multi-chemotherapeutic regimens IGF-1…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: